chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Confusional state, Diuretic therapy, Dyspnoea
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Echocardiogram, Echocardiogram abnormal, Ejection fraction normal, Electrocardiogram, Fibrin D dimer increased
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hyperkalaemia, Hypertension, Intensive care, Laboratory test abnormal, Left ventricular failure
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lung opacity, Metabolic encephalopathy, Myocardial ischaemia, Nephropathy, Pacemaker generated rhythm
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pleural effusion, Positive airway pressure therapy, Pulmonary hypertension, Pulmonary oedema, Renal atrophy
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory failure, Right ventricular dilatation, Right ventricular systolic pressure, SARS-CoV-2 test positive, Staphylococcus test positive
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Troponin increased, Ultrasound Doppler normal, Ultrasound kidney abnormal, Ventilation/perfusion scan, Ventricular hypokinesia
Clinical narrative: Patient is a 84 y.o. male with a history hard of hearing, Afib on AC, NICM with reduced EF, pacemaker, IDDM2, CKD, OSA on CPAP who presented to medical center with SOB and recent COVID positive 2/12/23. Found to have acute hypoxic hypercarbic RF, elevated d-dimer, Echo with positive McConnel sign and transferred to hospital 2/23/2023 for further management. Course complicated by continuous BiPAP requiring transfer to MICU and further complicated by bacteremia, AKI, hyperkalemia.    1. Acute on Chronic Hypoxic Respiratory Failure: Baseline 2-4L O2 by NC (per family member) with known COPD and CHF. Acute component due to pulmonary edema, COPD, and COVID infection. Required continuous BiPAP on admit with OLH CXR: left base opacity felt to be atelectasis. Weaned to baseline oxygen at discharge  2. COVID Infection: Positive home test 2/12/23 with positive PCR 2/23/23. Vaccinated with Pfizer x5, last 9/2022. Out of window for supplemental therapies, on Decadron (last dose 3/5/23). Improved. Isolation ended 3/1/23. 3. Elevated D-dimer: D-dimer 3018 but on renal reduced AC.  VQ scan at OLH low prob PE. OLH TTE mild to moderate right ventricular size, positive McConnel sign, RVSP 35. RMH TTE 2/24/23 EF 60%, mildly dilated right ventricle with mild hypokinesis, biatrial enlargement. Bilateral lower extremity dopplers 2/24/23 without DVT. S/p heparin gtt, transitioned to home renally dosed Eliquis. Low suspicion for PE but remains on AC regardless for other indication (atrial fibrillation).  4. Bacteremia: Blood cultures 2/2 positive for staph epidermis and 1/2 positive for lactococcus garvieae on 2/23/23. TEE 3/1/23 did not reveal signs of endocarditis or pacemaker infection. IV Vanco transitioned to Cefazolin -> linezolid. Infectious disease followed 5. AKI on CKD IIIb: Follows with Dr. (Neph). Atrophic left kidney. Cr 2.05 2/3/23, uptrended to 3.6 at OLH. Renal US 2/24/23 c/w medical renal disease. Cr improved with diuresis. Nephrology followed and recommended continued supportive care. Cr improved to presumed new baseline, creatinine 1.5 at time of discharge  6. Recurrent Hyperkalemia: Present on admission, >5 and then peaked to 6.2 on 2/24/23. EKG v-paced without peaked T waves. Asymptomatic. Potassium 5.0, 4.9, 5.1 on days leading up to discharge  7. Acute on Chronic diastolic CHF with pulmonary HTN.  TTE as discussed, no pericardial effusion. Admission BNP 10k. CXR 2/23/23 with small left pleural effusion. S/p IV diuresis. Continued GDMT and lasix at discharge  8. Acute metabolic encephalopathy: Noted inpatient at times with reported waxing/waning confusion. Likely multifactorial due to above medical issues. Resolved at time of discharge  9. Elevated Troponin: initial 54, EKG V-paced without ischemic changes. Denied CP. Suspect demand ischemia. TTE as above. No further workup  10. Atrial fibrillation, hypertension, coronary artery disease, Type 2 Diabetes: management unchanged at discharge
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blood urine present, Computerised tomogram kidney abnormal, Dyspnoea, Laboratory test, Nephrectomy
Clinical narrative: On 10/23/2022, I had blood in my urine and went to urgent care assuming it was a UTI. I was given cefalexin and they sent the urine sample off for evaluation. When I followed up with the NP, she recommended that I go see a urologist just to make sure it wasn't cancer. I went to a doctor that I haven't been to before. I went for one visit and he recommended that I get a CT scan. The CT scan showed a large mast on my kidney. He referred me to a choice of two surgeons. A family friend recommended me to the surgeon that I saw. I had surgery the Monday after the holiday and removed the kidney with the tumor. All the margins were clear, lymph nodes were clear. I was started on KEYTRUDA in February as a precautionary thing to self reduce the chance that something may occur and we're monitoring how I am with the medication. I'm waiting on the biopsy for my thyroid nodules as well. Next week I'm getting an echocardiogram and an EKG to see about some recent shortness of breath. They noted that the tumor had been on my kidney for some time because it was so big.
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Renal mass, Renal neoplasm, Urinary tract infection
Clinical narrative: On 10/23/2022, I had blood in my urine and went to urgent care assuming it was a UTI. I was given cefalexin and they sent the urine sample off for evaluation. When I followed up with the NP, she recommended that I go see a urologist just to make sure it wasn't cancer. I went to a doctor that I haven't been to before. I went for one visit and he recommended that I get a CT scan. The CT scan showed a large mast on my kidney. He referred me to a choice of two surgeons. A family friend recommended me to the surgeon that I saw. I had surgery the Monday after the holiday and removed the kidney with the tumor. All the margins were clear, lymph nodes were clear. I was started on KEYTRUDA in February as a precautionary thing to self reduce the chance that something may occur and we're monitoring how I am with the medication. I'm waiting on the biopsy for my thyroid nodules as well. Next week I'm getting an echocardiogram and an EKG to see about some recent shortness of breath. They noted that the tumor had been on my kidney for some time because it was so big.
Age: 84.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Chills, Exposure to SARS-CoV-2, Eye irritation, Feeling of body temperature change
Clinical narrative: I got COVID-19 from my son.  I felt chills and my eyes felt like they were burning and my forehead was warm.  I took a COVID-19 test and I test positive.  I felt hot and cold at the same time.  I immediately called the doctors office and they called me back within the hour and my doctor prescribed Paxlovid.  She also gave me a lot of information on what to do and what to expect. I began taking the Paxlovid the same day. Still having post-nasal drip.
Age: 84.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test positive, Skin warm, Upper-airway cough syndrome
Clinical narrative: I got COVID-19 from my son.  I felt chills and my eyes felt like they were burning and my forehead was warm.  I took a COVID-19 test and I test positive.  I felt hot and cold at the same time.  I immediately called the doctors office and they called me back within the hour and my doctor prescribed Paxlovid.  She also gave me a lot of information on what to do and what to expect. I began taking the Paxlovid the same day. Still having post-nasal drip.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Asthma, Blood test, Computerised tomogram, Condition aggravated
Clinical narrative: PHENOMENA, HAIR LOSS, HAIR AND SKIN DRYNESS, ASTHMA WORSENED, COPD, APPETITE DECREASED, HEARING AND EYE SIGHT WORSENED RAPIDLY,  OSTEOPOROSIS, ABILITY TO SMELL DECREASED,  RAPID SEVERE AGING,  QUALITY OF LIFE DECREASED EXTREMELY
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dry skin, Hair texture abnormal, Hypoacusis, Hyposmia
Clinical narrative: PHENOMENA, HAIR LOSS, HAIR AND SKIN DRYNESS, ASTHMA WORSENED, COPD, APPETITE DECREASED, HEARING AND EYE SIGHT WORSENED RAPIDLY,  OSTEOPOROSIS, ABILITY TO SMELL DECREASED,  RAPID SEVERE AGING,  QUALITY OF LIFE DECREASED EXTREMELY
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Osteoporosis, Pneumonia, Premature ageing, Quality of life decreased
Clinical narrative: PHENOMENA, HAIR LOSS, HAIR AND SKIN DRYNESS, ASTHMA WORSENED, COPD, APPETITE DECREASED, HEARING AND EYE SIGHT WORSENED RAPIDLY,  OSTEOPOROSIS, ABILITY TO SMELL DECREASED,  RAPID SEVERE AGING,  QUALITY OF LIFE DECREASED EXTREMELY
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: PHENOMENA, HAIR LOSS, HAIR AND SKIN DRYNESS, ASTHMA WORSENED, COPD, APPETITE DECREASED, HEARING AND EYE SIGHT WORSENED RAPIDLY,  OSTEOPOROSIS, ABILITY TO SMELL DECREASED,  RAPID SEVERE AGING,  QUALITY OF LIFE DECREASED EXTREMELY
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/23/2021 J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/23/2021
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Bladder catheterisation, Blood creatinine increased, Blood lactic acid normal
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood sodium decreased, C-reactive protein abnormal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Culture urine negative, Dyspnoea, Haemoglobin decreased
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hyponatraemia, Hypophagia, Leukocytosis, Lung opacity, Malaise
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oedema, Oxygen saturation decreased, Pneumonia, Pneumonia bacterial, Pneumonia viral
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Procalcitonin increased, Pulmonary function test abnormal, SARS-CoV-2 test positive, Sepsis, Superinfection
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Tachypnoea, Urine analysis abnormal
Clinical narrative: The patient is a 86 y.o. male patient of MD with history of CAD, hypertension, hyperlipidemia, COPD, hypothyroidism, CAD, myocardial infarction, prostate cancer s/p resection and RT, and squamous cell cancer of the left calf. who presented to the Hospital with shortness of breath.   Sepsis due to Viral and bacterial pneumonia Acute Hypoxic Respiratory Failure, due to COVID 19 Pneumonia and Superimposed Bacterial Pneumonia COPD Exacerbation Desaturated to the 70s on room air. Afebrile, tachypneic and with leukocytosis on admission. Now all improving. Lactate WNL. Required 5L NC on admission, weaned to 3L today Recently started on Augmentin for possible CAP Positive COVID test  3/2/23 CXR interstitial and alveolar opacities about the mid and lower lung zones. Superimposed multilobar pneumonia in the distribution of the right middle lobe and lower lobes as well as lingula is difficult to exclude Procalcitonin elevated so likely superimposed bacterial infection present Continue Unasyn IV Dexamethasone ordered, Symptoms started 10-14 days prior to admission, no Remdesivir ordered CRP improving Albuterol PRN On trelegy at home, continued as Spiriva and Symbicort here May require prolonged wean off supplemental O2 given severity of COPD in last PFT's. Discharged home on home oxygen, requiring 4L via NC during exertion and 2L NC at rest. Discussed following up with PCP and Pulmonologist Course of Dexamethasone and Augmentin (previously prescribed and at home) prescribed on discharge to complete treatment   Hyponatremia, mild AKI- resolved Sodium 127 on admission, improved to 130, now 126 again Cr initially 1.34, now down to normal.  Suspect due to poor PO intake initially. Mmild edema noted on 3/4, Lasix 20 mg given, Na remains 126. Will start salt tablets.  Check Osm u/p CoUrinary Tract Infection, ruled out Urinary Retention s/p Suprapubic catheter History of Prostate cancer UA suggestive of infection Urine culture with no growth No specific urinary symptoms, but SPC in place Unasyn for CAP as above anyways, but culture confirmed no UTI   CAD Hypertension Hyperlipidemia Currently no chest pain Continue home aspirin, atorvastatin, and diltiazem   Chronic normocytic anemia Due ot chronic disease, Hb ~10-11 since January No signs of bleeding. Monitor   Hypothyroidism Continue home levothyroxine   Depression/Anxiety Continue home amitriptyline ntinue to monitor
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain
Clinical narrative: Patient experienced soreness about 1 day after vaccination and slowly increased over the past few months, with noticeable concern beginning last month (early March 2023).   Patient's soreness and pain level has increased to where reporting it as an adverse event would be warranted.  Patient reached out to pharmacy on 3/31/2023.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Given from outside source per patient report
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: pt was confused.  she presented with a copy of her vaccine card but forgot she received the booster 9-22-2022.  No adverse effects noted at the time of this submission.
Age: 86.0
Sex: F
Vaccine: COVID19-2, PNC20
Symptoms: Breath sounds abnormal, Hyperhidrosis, Hypotension, Pallor, Respiratory rate increased
Clinical narrative: Increased respirations 44 RR/minute with maintained SpO2 at 90%. Floor nurse had switched resident to higher flow oxygenation at 6L/minute to maintain 90%. Bilateral lung sounds assessed to show no lung sounds in right upper and lower lobe, left lobes remain clear. Pallor evident. Resident is diaphoretic to touch and not responsive to verbal or tactile stimulation including sternal rub. Tachycardia noted at 117 bpm, hypotensive at 89/54.
Age: 86.0
Sex: F
Vaccine: COVID19-2, PNC20
Symptoms: Tachycardia, Troponin increased, Unresponsive to stimuli, Urosepsis
Clinical narrative: Increased respirations 44 RR/minute with maintained SpO2 at 90%. Floor nurse had switched resident to higher flow oxygenation at 6L/minute to maintain 90%. Bilateral lung sounds assessed to show no lung sounds in right upper and lower lobe, left lobes remain clear. Pallor evident. Resident is diaphoretic to touch and not responsive to verbal or tactile stimulation including sternal rub. Tachycardia noted at 117 bpm, hypotensive at 89/54.
Age: 58.0
Sex: F
Vaccine: COVID19-2, VARZOS
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I woke up with a running nose, fatigue, cough, and a slight sore throat. The second day I saw a nurse at an urgent care, and she tested me for COVID-19 which was positive. I got a prescription for Paxlovid. I started feeling better day 4-5 of taking Paxlovid but my cough lasted for a couple weeks. I didn't test negative for COVID-19 until the 16th day. I still occasionally have a cough.
Age: 58.0
Sex: F
Vaccine: COVID19-2, VARZOS
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I woke up with a running nose, fatigue, cough, and a slight sore throat. The second day I saw a nurse at an urgent care, and she tested me for COVID-19 which was positive. I got a prescription for Paxlovid. I started feeling better day 4-5 of taking Paxlovid but my cough lasted for a couple weeks. I didn't test negative for COVID-19 until the 16th day. I still occasionally have a cough.
Age: 78.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Brain fog, Dizziness, Feeling abnormal, Headache, Laboratory test
Clinical narrative: 1 week after the first dose had vertigo. was prescribed meclezine on 9/7/2022.  since then hasn't felt the same . had long lasting dizziness, brain foggy, headaches.  was prescribed topiramate .
Age: 78.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Malaise, Vertigo
Clinical narrative: 1 week after the first dose had vertigo. was prescribed meclezine on 9/7/2022.  since then hasn't felt the same . had long lasting dizziness, brain foggy, headaches.  was prescribed topiramate .